Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00091039 · ClinicalTrials.gov registry record · NA
Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
A NA study of Lung Cancer, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00091039: Completed NA study of Lung Cancer, sponsored by National Cancer Institute (NCI).
NCT00091039 is a NA study of Lung Cancer that has completed, run by National Cancer Institute (NCI). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00091039, a NA study of Lung Cancer, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
RATIONALE: Vaccines made from a gene-modified virus may make the body build an immune response to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy x-rays to damage tumor cells. Combining vaccine therapy with chemotherapy and radiation therapy may kill more tumor cells. PURPOSE: This clinical trial is studying how well giving vaccine therapy together with paclitaxel, carboplatin, and radiation therapy works in treating patients with stage III non-small cell lung cancer that cannot be removed with surgery.
Conditions Studied
Interventions
- DRUG carboplatin
- DRUG paclitaxel
- BIOLOGICAL recombinant fowlpox GM-CSF vaccine adjuvant
- BIOLOGICAL recombinant fowlpox-CEA(6D)/TRICOM vaccine
- BIOLOGICAL recombinant vaccinia-CEA(6D)-TRICOM vaccine
Study Locations (1)
Maryland
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support - Bethesda
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-08 |
| Est. Completion | 2006-02 |
| Phase | NA |
What the finished NCT00091039 record still lists
NCT00091039 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which carboplatin is the first listed.
NCT00091039 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00091039 about?
NCT00091039 is a clinical study titled "Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery". RATIONALE: Vaccines made from a gene-modified virus may make the body build an immune response to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy...
What is the current status of trial NCT00091039?
This trial is currently completed. It is a NA study. The study started on 2004-08. Estimated completion is 2006-02.
What conditions does trial NCT00091039 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00091039?
The interventions under investigation include: carboplatin (DRUG), paclitaxel (DRUG), recombinant fowlpox GM-CSF vaccine adjuvant (BIOLOGICAL), recombinant fowlpox-CEA(6D)/TRICOM vaccine (BIOLOGICAL), recombinant vaccinia-CEA(6D)-TRICOM vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00091039?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00091039 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia